GGrantIndex
← Search

CORE--SPECTROSCOPY SUPPORT

$114,964P30FY2005CANIH

Fox Chase Cancer Center, Philadelphia PA

Investigators

Linked publications, trials & patents

Paper 39604567Paper 39602533Paper 39554190Paper 39546469Paper 39521739Paper 39514554Paper 39371220Paper 39345610Paper 39343653Paper 39223207Paper 39207123Paper 39189642Paper 39148468Paper 39137728Paper 39072643Paper 39060143Paper 39013784Paper 39003201Paper 38982062Paper 38976159Paper 38963567Paper 38914477Paper 38871720Paper 38865671Paper 38853421Paper 38835516Paper 38815457Paper 38811332Paper 38798370Paper 38766032Paper 38747616Paper 38678525Paper 38659828Paper 38639476Paper 38638131Paper 38600381Paper 38586274Paper 38586042Paper 38559274Paper 38547779Paper 38539515Paper 38464238Paper 38452871Paper 38432028Paper 38421650Paper 38377387Trial NCT04290585Trial NCT03177057Trial NCT02594826Trial NCT02132884Trial NCT02132858Trial NCT02132845Trial NCT02110953Trial NCT02092714Trial NCT02050009Trial NCT01982591Trial NCT01962948Trial NCT01934179Trial NCT01840150Trial NCT01462630Trial NCT01316757Trial NCT01212822Trial NCT00750009Trial NCT00509626Trial NCT00458588Trial NCT00436397Trial NCT00433524Trial NCT00084591Trial NCT00084539Trial NCT00084526Trial NCT00084513Trial NCT00066677Trial NCT00062322Trial NCT00062309Trial NCT00043108Trial NCT00039520Trial NCT00039507Trial NCT00022308Trial NCT00021398Trial NCT00021372Trial NCT00021346Trial NCT00021333Trial NCT00021320Trial NCT00005037Trial NCT00003264Trial NCT00003263Trial NCT00003109Patent 9533040Patent 9182383Patent 9101603Patent 8980258Patent 8685658Patent 8609437Patent 8580263Patent 8329873Patent 7332585Patent 7332580Patent 7129057Patent 6946275Patent 6617427

Abstract

The services offered by the Spectroscopy Support Facility (SSF) cover two distinct areas: 1) applications of nuclear magnetic resonance (NMR), circular dichroism, and fluorescence spectroscopy for studies of biomolecular structure and function, and 2) magnetic resonance microscopy (MRM) for In vivo imaging of small animals especially relevant to cancer research. The Facility houses two well equipped NMR instruments, a 600 MHz (14 Tesla) magnet with a Bruker DMX-600 console, a wide-bore 300 MHz (7 Tesla) magnet with a Bruker DRX-300 console, including a Biospec microimaging accessory. Facility personnel maintain and operate the spectrometers, perform NMR analytical and small-animal imaging services, and offer expert advice and technical support to users. The 600 MHz instrument is fully equipped for heteronuclear multidimensional NMR studies on the structure, dynamics and interactions of biological macromolecules. The 300 MHz instrument is well suited for multinuclear analysis of small molecules and studies of enzyme function involving isotopically-labeled ligands. Small-animal imaging on the 300 MHz instrument is of interest to investigators studying mouse models of cancer. MRM permits monitoring of tumor development, growth, perfusion, vascularization, and response to treatment. New capabilities for optical imaging are being implemented in order to study tumors expressing luminescent or fluorescent proteins in small-animal models. The Spectroscopy Support Facility was rated "Very Good to Excellent" at the last review. In 2003, the Facility was used by 18 peer-reviewed, funded investigators from 9 different Programs in all three Divisions. This represents an 80% increase over the number of users five years ago and addresses the previous concern that the Facility primarily served a small number of investigators in the Biomolecular Structure and Function Program. The broadened impact of the Facility is largely due to the implementation of small animal imaging, which made it possible to support cancer-related research Programs by eight additional users from all three Divisions. After the MR ilmaging services became fully operational, the usage of the 300 MHz instrument increased by two-fold. Over 99% of the total usage is by peer-reviewed, funded investigators. Data obtained with the help of the Facility have resulted in 27 publications in peer-reviewed journals over the past five years.

View original record on NIH RePORTER →